Cell number and transfection volume dependent peptide nucleic acid antisense activity by cationic delivery methods.
Efficient intracellular delivery is essential for high activity of nucleic acids based therapeutics, including antisense agents. Several strategies have been developed and practically all rely on auxiliary transfection reagents such as cationic lipids, cationic polymers and cell penetrating peptides as complexing agents and carriers of the nucleic acids. However, uptake mechanisms remain rather poorly understood, and protocols always require optimization of transfection parameters. Considering that cationic transfection complexes bind to and thus may up-concentrate on the cell surface, we have now quantitatively compared the cellular activity (in the pLuc705 HeLa cell splice correction system) of PNA antisense oligomers using lipoplex delivery of cholesterol- and bisphosphonate-PNA conjugates, polyplex delivery via a PNA-polyethyleneimine conjugate and CPP delivery via a PNA-octaarginine conjugate upon varying the cell culture transfection volume (and cell density) at fixed PNA concentration. The results show that for all delivery modalities the cellular antisense activity increases (less than proportionally) with increasing volume (in some cases accompanied with increased toxicity), and that this effect is more pronounced at higher cell densities. These results emphasize that transfection efficacy using cationic carriers is critically dependent on parameters such as transfection volume and cell density, and that these must be taken into account when comparing different delivery regimes.
Department of Cellular and Molecular Medicine, Faculty of Health Sciences, The Panum Institute, University of Copenhagen, Copenhagen, Denmark.
Laia
L
Llovera
Peter
P
Berthold
Peter E
PE
Nielsen
Takehiko
T
Shiraishi
D002452:Cell Count; D002784:Cholesterol / Q000008:administration & dosage / Q000737:chemistry; D004164:Diphosphonates / Q000008:administration & dosage / Q000737:chemistry; D006367:HeLa Cells; D006801:Humans; D016376:Oligonucleotides, Antisense / Q000008:administration & dosage* / Q000737:chemistry; D009842:Oligopeptides / Q000008:administration & dosage / Q000737:chemistry; D020135:Peptide Nucleic Acids / Q000008:administration & dosage* / Q000737:chemistry; D011094:Polyethyleneimine / Q000008:administration & dosage / Q000737:chemistry; D014162:Transfection / Q000379:methods*
D004164:Diphosphonates; D016376:Oligonucleotides, Antisense; D009842:Oligopeptides; D020135:Peptide Nucleic Acids; C448619:octaarginine; D011094:Polyethyleneimine; D002784:Cholesterol